These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5976469)

  • 1. [Haptoglobin kinetics and enzyme activity in acute hepatitis, mechanical icterus and liver cirrhosis].
    Kallai L; Keler-Bacoka M; Blazkević K; Knĕzević S
    Cesk Gastroenterol Vyz; 1966 Sep; 20(6):398-407. PubMed ID: 5976469
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of theophylline in patients with liver diseases.
    Staib AH; Schuppan D; Lissner R; Zilly W; von Bomhard G; Richter E
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):500-2. PubMed ID: 7203726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol turnover in patients with chronic liver disease.
    Sandhofer F; Bolzano K; Sailer S; Braunsteiner H
    Eur J Clin Invest; 1973 Jan; 3(1):10-5. PubMed ID: 4687401
    [No Abstract]   [Full Text] [Related]  

  • 4. [Formation and excretion of bile acid sulfates: an important protective mechanism in cholestasis].
    Stiehl A
    Verh Dtsch Ges Inn Med; 1973; 79():948-50. PubMed ID: 4790051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypnotics and sedatives in liver diseases (summary of session 4)].
    Z Gastroenterol Verh; 1976; (12):203-20. PubMed ID: 73293
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in thyroxine-binding capacity in liver diseases].
    Pottkämper G; Gatz J; Schwinn G; Hesch RD; Köbberling J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():322-5. PubMed ID: 829382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hydrocortisone on the activity of plasma and hepatic tissue enzymes. I. Leucylaminopeptidase (LAP) and glycylaminopeptidase (GAP) activity in experimental liver cirrhosis and mechanical jaundice in rats].
    Drozdz H
    Przegl Lek; 1971; 28(12):765-70. PubMed ID: 5139319
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of neonatal galactosemia].
    Savasteeva NV; Dobroskokova NF; Zhukova VA; Nadeev AP; Aksenova VP; Travin MA
    Arkh Patol; 2010; 72(1):41-2. PubMed ID: 20369586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interpretation of haptoglobin values in the diagnosis of liver disease.
    Kallai L; Keler-Bacoka M; Blazević K; Knezević S
    Gastroenterologia; 1966; 105(1):27-34. PubMed ID: 5905802
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma angiotensinase activity in liver disease.
    Kokubu T; Ueda E; Fujimoto S; Hiwada K; Sanga H; Yamamura Y
    Clin Chim Acta; 1965 Nov; 12(5):484-8. PubMed ID: 4286226
    [No Abstract]   [Full Text] [Related]  

  • 15. [The activity of alkaline and acid phosphatase in chronic hepatitis and cirrhosis of the liver].
    Gupalo EE
    Arkh Patol; 1965; 27(10):66-70. PubMed ID: 5871295
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion of free fatty acids to triglycerides. Determination in obstructive vs hepatocellular jaundice, and cirrhosis.
    Santos M; Friedberg SJ; Kudzma DJ; Tjoa LT
    Arch Intern Med; 1974 Sep; 134(3):457-60. PubMed ID: 4851179
    [No Abstract]   [Full Text] [Related]  

  • 17. Further evidence for the superiority of a 3-compartmental model for distribution analyses of i.v. injected bile acids in men: studies in patients with liver diseases.
    Klapdor R
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):23-5. PubMed ID: 425798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of iron metabolism in cases of hepatitis and liver cirrhosis.
    Stojcevski T; Grunevska B; Davcev P; Marković V
    Acta Med Iugosl; 1970; 24(1):41-8. PubMed ID: 5455213
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemistry of bile acids in health and disease.
    Danielsson H; Gustafsson J
    Pathobiol Annu; 1981; 11():259-98. PubMed ID: 7036053
    [No Abstract]   [Full Text] [Related]  

  • 20. [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].
    Bacq Y; Schillio Y; Brechot JF; De Muret A; Dubois F; Metman EH
    Gastroenterol Clin Biol; 1993; 17(5):364-9. PubMed ID: 8349072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.